Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dallah Healthcare CoSAU:4004 -0.92%92 Buyback Yield % is 0.15 as of Jul. 29, 2026, which is 95% below its 10-year median of 2.91. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼206.76 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 62.32% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Dallah Healthcare Co Buyback Yield % Related Terms
Dallah Healthcare Co Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Buyback Yield % of 0.15 as of Jul. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Dallah Healthcare Co and its competitors. This is 95% below median its historical median of 2.91. Over the past decade, Dallah Healthcare Co's Buyback Yield % has ranged from 0.11 to 5.71. According to the industry distribution chart, Dallah Healthcare Co ranks #104 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 37.7%.
Is Dallah Healthcare Co's Buyback Yield % too high?
Dallah Healthcare Co's current Buyback Yield % of 0.15 is 95% below median its 10-year median of 2.91. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 5.71. Based on the distribution chart, Dallah Healthcare Co ranks #104 out of 276 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #104 out of 276 companies for Buyback Yield %. This puts Dallah Healthcare Co in the upper half of its industry. Historically, Dallah Healthcare Co's own Buyback Yield % has ranged from 0.11 to 5.71 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Dallah Healthcare Co and its competitors. Dallah Healthcare Co's current Buyback Yield % is 0.15, which is 95% below median its own 10-year median of 2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼206.76, compared to a current price of ﷼107.60 — trading 48% below its estimated fair value. The current Buyback Yield % is 0.15, which is 95% below median its 10-year median of 2.91. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Buyback Yield % is 0.15 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼107.60 is trading 48% below its estimated GF Value™ of ﷼206.76.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
Buyback Yield %: 0.15 (95% below median its 10-year median of 2.91)
GF Value™: ﷼206.76 vs. price of ﷼107.60 (48% below fair value)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score
Get the complete analysis for SAU:4004
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
